Lung Cancer
Conference Coverage
In metastatic NSCLC, better QoL outcomes tied to better outcomes
But the authors of new research also found potential evidence that industry sponsorship may lead to a spin on QoL outcomes.
From the Journals
SBRT: Alternative to surgery in early stage lung cancer?
“From a public health perspective, SBRT is a good therapeutic option in terms of survival, especially for elderly and inoperable patients.”
From the Journals
Depression tied to inflammation and survival in lung cancer
A new study’s findings underscore the importance of assessing and treating depression in patients with cancer, particularly given the high rate of...
Networks
Breathing easier: The growing adoption of indwelling pleural catheters
The management of recurrent pleural effusions is challenging.
Feature
Myths about smoking, diet, alcohol, and cancer persist
A new study shows how thinking has changed over time and how difficult it is to alter preconceived notions.
From the Journals
Advanced imaging technology could help predict lung cancer progression after surgery
“AI can predict clinical outcomes when combined with [imaging mass cytometry] with extremely high accuracy from a single 1-mm2 tumor core.”
Opinion
Postop RT: Meaningful survival improvement in N2 lung cancer
“When you have patients with N2 disease, after the completion of systemic therapies, think about the use of PORT and get the advice of a radiation...
Feature
Could your patients benefit? New trials in lung cancer
Patients with untreated advanced non–small cell lung cancer (NSCLC) can join one of these randomized, open-label, phase 3 studies.
From the Journals
Less invasive NSCLC surgery does not compromise survival
New results contrast with those from a previous study from 1995.
Perspectives
Three wild technologies about to change health care
Now, in the 23rd year of the 21st century, you might not believe what we’ll be capable of next.